Hematologic Disease clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for

  • Gene Transfer Study for Hemophilia A

    “This research study will help us learn if the study product (SPK-8011) is safe and effective in reducing bleeding for treating hemophilia A.”

    open to eligible males ages 18 years and up

    This clinical research study is being conducted by Spark Therapeutics, Inc. to determine the safety and efficacy of the factor VIII gene transfer treatment with SPK-8011 in individuals with hemophilia A.

    Portland 5746545, Oregon 5744337 and other locations

  • Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

    “We are looking for people age 12 to 65 years old with SCD to help test a drug trying to reduce the number of vaso-occlusive crises”

    open to eligible people ages 12-65

    This clinical trial is a Phase 2/3 study that will evaluate the efficacy and safety of etavopivat and test how well etavopivat works compared to placebo to improve the amount of hemoglobin in the blood and to reduce the number of vaso-occlusive crises (times when the blood vessels become blocked and cause pain).

    Long Beach 5367929, California 5332921 and other locations

Last updated: